[Efficacy and Safety of High-dose Furmonertinib plus Intrathecal Pemetrexed  for EGFR-mutant Non-small Cell Lung Cancer with Leptomeningeal Metastasis]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.